Nausea and Vomiting In Patients Receiving Consecutive Days of Cisplatin

Sidney Kimmel Cancer Center at Thomas Jefferson University8 enrolled

Overview

The purpose of this study is to observe the incidence of nausea with systemic chemotherapy that includes consecutive days (more than one day)of cisplatin medication.

Questionnaires are completed on week of chemotherapy treatment referred to as Dartmouth regimen.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Metastatic Melanoma Nausea

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * confirmed diagnosis metastatic melanoma * 18 years and older * undergoing chemotherapy with Dartmouth regimen * medically stable to receive chemotherapy per physical and clinical laboratory tests Exclusion Criteria: * No medical conditions that interfere with assessment of nausea and vomiting during chemotherapy * No cognitive disorder that impairs symptom assessment * No other investigational agent * Inability to swallow medications for nausea and vomiting * No gastric outlet obstruction

Locations (1)

Thomas Jefferson University Hospital

Philadelphia, Pennsylvania, United States

Outcomes

Primary Outcomes

Determine incidence of nausea when receiving Dartmouth regimen chemotherapy for metastatic melanoma

Time frame: Week of treatment

Secondary Outcomes

Assess the impact of systemic chemotherapy with Dartmouth regimen on quality of life of patients

Time frame: week of treatment

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.